Analysis of Language and Speech in Patients with Frontotemporal Dementia (FTD)

Printer-friendly version

Winterlight Labs, a technology company, and Alector, a biopharmaceutical company based in San Francisco, are partnering to conduct a speech assessment study in persons diagnosed with behavioral variant FTD (bvFTD) or primary progressive aphasia (PPA). The purpose of the study is to evaluate whether an in-home speech assessment that uses an iPad application can detect changes in how the brain processes information in FTD. By analyzing how you speak, Winterlight Labs and Alector may be able to detect changes in brain information processing that cannot be detected with other tests.

You may be eligible to participate in this study if:

    • You are between the ages of 45 and 90
    • You have been diagnosed with bvFTD or PPA within the past 12 months
    • You have a relative or caregiver who can administer the assessments

Winterlight will send study participants an iPad in the mail. Over a 12-month period, participants will complete a series of six short assessments on the iPad using the Winterlight app. Each assessment should take about 15 minutes to complete. At the end of the study, participants will be able to keep the iPad.

If you are interested in participating in this study, you can contact Winterlight Labs by calling toll-free to 1-833-WINLABS (1-833-946-5227) or via email: [email protected].